Chronic cough, defined as a cough lasting more than eight weeks, is a common yet perplexing clinical challenge. Despite its prevalence, the underlying etiologies often remain elusive, leading to diagnostic dilemmas and therapeutic frustrations. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Chronic cough is usually a symptom of an underlying condition such as asthma, gastroesophageal reflux disease (GERD), or upper airway cough syndrome (UACS). Other less common causes include bronchiectasis, chronic obstructive pulmonary disease (COPD), and lung cancer. The pathophysiology of chronic cough involves a complex interplay between the cough reflex pathway and various inflammatory, mechanical, or chemical stimuli.
A thorough history and physical examination are paramount in the evaluation of chronic cough. Special attention should be given to the patient's medication history, as drugs like angiotensin-converting enzyme (ACE) inhibitors can induce cough. Diagnostic tests such as spirometry, chest X-ray, and bronchoscopy can be useful depending on the suspected underlying cause. In some cases, a trial of treatment may be warranted to confirm the diagnosis.
The management of chronic cough should be targeted at the underlying cause. This may involve pharmacological treatment, such as inhaled corticosteroids for asthma or proton pump inhibitors for GERD. Non-pharmacological interventions, such as lifestyle modifications and pulmonary rehabilitation, can also be beneficial. Refractory cases may require referral to a specialist for further evaluation and management.
Chronic cough is a multifaceted clinical problem that requires a comprehensive and individualized approach. By understanding the potential etiologies, employing a systematic diagnostic process, and tailoring the management plan to the underlying cause, clinicians can effectively diagnose and manage chronic cough, thereby improving patient outcomes and quality of life.
1.
Health researchers discuss Medicaid cancer screening trends, best practices
2.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
3.
Approved BTK Inhibitor Without Covalent Bond for CLL.
4.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
5.
AI-based breast cancer risk technology receives FDA breakthrough device designation
1.
Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms
2.
Innovative Solutions in Hematology for Specialists
3.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
4.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
5.
Evidence-Based Insights in Oncology for Specialists
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation